CAS: 129-49-7; Methysergide Maleate Salt

该化合物是一种合成化合物,主要以其用于治疗偏头痛和集束头痛而闻名;它是淋巴酸的衍生物,并起到血清素受体对抗作用,特别是在5-HT2受体地点;该物质似乎是白色的,以白白为异白晶状粉,通常以平板形式施用;甲状腺素阳性以水溶性相对较低为特征,可影响其生物利用率和药用植物基系.它具有中度半衰期,允许在临床环境中每天服用一两次.然而,长期使用可导致副作用,包括后皮囊纤维化和肺炎高血压,需要仔细监测病人.由于这些潜在有害影响,其使用已变得不常见,在其他治疗失败时,它往往被考虑. 甲状腺素阳性甲状腺素被归入可感官甲状腺素的类别,因为其特性是已知的.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    📜N-(1-Hydroxybutan-2-yl)-7-Methyl-4,6,6A,7,8,9-Hexahydroindolo[4,3-Fg]Quinoline-9-Carboxamide 反应生成马来酸美西麦角
    参考文献:1-Methyl Ergotamines And Ergocornines
    标题:1-Methyl Ergotamines And Ergocornines
    摘要:该发明涉及公式(i)的n1-取代的麦角酸衍生物;其中r1是甲氧基,羟基烷基氨基,氨基,单或双烷基氨基或1-吡咯烷基,或天然水不溶性麦角生物碱的三肽基团,R2是甲基,乙基,烯丙基或苄基,\sg是<;Form:0811964/iv(b)/2>;"烷基"表示含有2或3个碳原子的烷基基团.该发明还涉及通过在液氨中用碱金属酰胺处理r2为氢的公式(i)中相应的化合物,并将所得的碱金属盐与z为卤素原子的化合物r2Z反应来制备这些衍生物.最好在-30oc和-60oc之间使用甲基或乙基碘进行反应.实例描述了麦角碱,麦角胺,麦角胺,二氢麦角胺,二氢麦角甲酸,二氢麦角晶,二氢麦角酮,麦角酸和异麦角酸酰胺,麦角酸乙酰胺,二乙酰胺和吡咯烷基酰胺的1-甲基衍生物,二氢麦角晶的1-乙基衍生物,以及二氢麦角晶,二氢麦角酮和二氢麦角甲酸的1-烯丙基和1-苄基衍生物的制备.还描述了1-甲基-麦角酸二乙酰胺和吡咯烷基酰胺的酒石酸盐.

    海关参考信息

    专利信息


    专利号:US-4331688-A
    优先权日:1978-02-23
    标题 :Therapeutic method for inhibiting gastric secretion by administration of 15-deoxy-16-hydroxy prostaglandins
    发明人:KLUENDER HAROLD C; WOESSNER WARREN D; BIDDLECOM WILLIAM G
    权利人:MILES LAB
    摘要:Analogues of PGE 1 having the structural formula, ##STR1## in which J is R-hydroxymethylene or S-hydroxymethylene; R 1 is hydrogen; R 2 is hydrogen or together with R 4 is a methylene chain of 2 to 3 carbon atoms such that a cycloalkyl of 5 to 6 carbon atoms inclusive is formed; R 3 is hydrogen or methyl, or together with R 4 is a methylene or a lower alkylated methylene chain of 2 to 5 carbon atoms such that a cycloalkyl or a lower alkylated cycloalkyl of 4 to 7 carbon atoms inclusive is formed, or together with R 4 is bicycloalkyl or bicycloalkenyl moiety having the formula: ##STR2## such that a bicycloalkyl or bicycloalkenyl compound is formed, wherein m and n are integers having a value from 0 to 3, p is an integer having a value from 0 to 4 and q is an integer having a value of from 1 to 4 and wherein the double bond of such bicycloalkenyl is in the m, n, p, or q bridge; R 4 is hydrogen or methyl or together with R 2 or R 3 forms a cycloalkyl or bicycloalkyl or bicycloalkenyl as defined above, or together with R 5 is a methylene chain of 3 to 5 carbon atoms such that a cycloalkyl of 4 to 6 carbon atoms inclusive is formed; R 5 is selected from the group consisting of hydrogen, straight-chain alkyl having from 1 to 3 carbon atoms or together with R 4 forms a cycloalkyl as defined above; and R 6 is hydrogen or straight-chain alkyl having from 1 to 3 carbon atoms are disclosed. n PGE 1 ester analogues of the above formula, limited to the structures wherein two of R 2 , R 3 R 4 and R 5 form a cycloalkyl, lower alkylated cycloalkyl, bicycloalkyl or bicycloalkenyl are also disclosed. n The prostaglandin analogues selectively produce bronchodilation and decrease gastric secretion in vivo. n Methods of preparing the analogues and starting materials required in the synthesis of the analogues are also disclosed.

    专利号:US-4132738-A
    优先权日:1978-02-23
    标 题:Preparation of 15-deoxy-16-hydroxyprostaglandins
    发明人:KLUENDER HAROLD C; WOESSNER WARREN D; BIDDLECOM WILLIAM G
    权利人:MILES LAB
    摘要:Analogues of PGE 1 having the structural formula, ##STR1## in which J is R-hydroxymethylene or S-hydroxymethylene; R 1 is hydrogen; R 2 is hydrogen or together with R 4 is a methylene chain of 2 to 3 carbon atoms such that a cycloalkyl of 5 to 6 carbon atoms inclusive is formed; R 3 is hydrogen or methyl, or together with R 4 is a methylene or a lower alkylated methylene chain of 2 to 5 carbon atoms such that a cycloalkyl or a lower alkylated cycloalkyl of 4 to 7 carbon atoms inclusive is formed, or together with R 4 is bicycloalkyl or bicycloalkenyl moiety having the formula: ##STR2## SUCH THAT A BICYCLOALKYL OR BICYCLOALKENYL COMPOUND IS FORMED, WHEREIN M AND N ARE INTEGERS HAVING A VALUE FROM 0 TO 3, P IS AN INTEGER HAVING A VALUE FROM 0 TO 4 AND Q IS AN INTEGER HAVING A VALUE OF FROM 1 TO 4 AND WHEREIN THE DOUBLE BOND OF SUCH BICYCLOALKENYL IS IN THE M, N, P, OR Q BRIDGE; R 4 is hydrogen or methyl or together with R 2 or R 3 forms a cycloalkyl or bicycloalkyl or bicycloalkenyl as defined above, or together with R 5 is a methylene chain of 3 to 5 carbon atoms such that a cycloalkyl of 4 to 6 carbon atoms inclusive is formed; R 5 is selected from the group consisting of hydrogen, straight-chain alkyl having from 1 to 3 carbon atoms or together with R 4 forms a cycloalkyl as defined above; and R 6 is hydrogen or straight-chain alkyl having from 1 to 3 carbon atoms are disclosed. n Pge 1 ester analogues of the above formula, limited to the structures wherein two of R 2 , R 3 R 4 and R 5 form a cycloalkyl, lower alkylated cycloalkyl, bicycloalkyl or bicycloalkenyl are also disclosed. n The prostaglandin analogues selectively produce bronchodilation and decrease gastric secretion in vivo. n Methods of preparing the analogues and starting materials required in the synthesis of the analogues are also disclosed.

    专利号:US-4415592-A
    优先权日:1978-02-23
    标 题 :15-Deoxy-16-hydroxy prostaglandins for producing bronchodilation
    发明人:KLUENDER HAROLD C; WOESSNER WARREN D; BIDDLECOM WILLIAM G
    权利人:MILES LAB
    摘要:Analogues of PGE 1 having the structural formula, ##STR1## in which J is R-hydroxymethylene or S-hydroxymethylene; R 1 is hydrogen; R 2 is hydrogen or together with R 4 is a methylene chain of 2 to 3 carbon atoms such that a cycloalkyl of 5 to 6 carbon atoms inclusive is formed; R 3 is hydrogen or methyl, or together with R 4 is a methylene or a lower alkylated methylene chain of 2 to 5 carbon atoms such that a cycloalkyl or a lower alkylated cycloalkyl of 4 to 7 carbon atoms inclusive is formed, or together with R 4 is bicycloalkyl or bicycloalkenyl moiety having the formula: ##STR2## such that a bicycloalkyl or bicycloalkenyl compound is formed, wherein m and n are integers having a value from 0 to 3, p is an integer having a value from 0 to 4 and q is an integer having a value of from 1 to 4 and wherein the double bond of such bicycloalkenyl is in the m, n, p, or q bridge; R 4 is hydrogen or methyl or together with R 2 or R 3 forms a cycloalkyl or bicycloalkyl or bicycloalkenyl as defined above, or together with R 5 is a methylene chain of 3 to 5 carbon atoms such that a cycloalkyl of 4 to 6 carbon atoms inclusive is formed; R 5 is selected from the group consisting of hydrogen, straight-chain alkyl having from 1 to 3 carbon atoms or together with R 4 forms a cycloalkyl as defined above; and R 6 is hydrogen or straight-chain alkyl having from 1 to 3 carbon atoms are disclosed. n PGE 1 ester analogues of the above formula, limited to the structures wherein two of R 2 , R 3 , R 4 and R 5 form a cycloalkyl, lower alkylated cycloalkyl, bicycloalkyl or bicycloalkenyl are also disclosed. n The prostaglandin analogues selectively produce bronchodilation and decrease gastric secretion in vivo. n Methods of preparing the analogues and starting materials required in the synthesis of the analogues are also disclosed.

    专利号:US-4275224-A
    优先权日:1978-02-23
    标题:15-Deoxy-16-hydroxy prostaglandins
    发明人:KLUENDER HAROLD C; WOESSNER WARREN D; BIDDLECOM WILLIAM G
    权利人:MILES LAB
    摘要:Analogues of PGE 1 having the structural formula, ##STR1## in which J is R-hydroxymethylene or S-hydroxymethylene; R 1 is hydrogen; R 2 is hydrogen or together with R 4 is a methylene chain of 2 to 3 carbon atoms such that a cycloalkyl of 5 to 6 carbon atoms inclusive is formed; R 3 is hydrogen or methyl, or together with R 4 is a methylene or a lower alkylated methylene chain of 2 to 5 carbon atoms such that a cycloalkyl or a lower alkylated cycloalkyl of 4 to 7 carbon atoms inclusive is formed, or together with R 4 is bicycloalkyl or bicycloalkenyl moiety having the formula: ##STR2## such that a bicycloalkyl or bicycloalkenyl compound is formed, wherein m and n are integers having a value from 0 to 3, p is an integer having a value from 0 to 4 and q is an integer having a value of from 1 to 4 and wherein the double bond of such bicycloalkenyl is in the m, n, p, or q bridge; R 4 is hydrogen or methyl or together with R 2 or R 3 forms a cycloalkyl or bicycloalkyl or bicycloalkenyl as defined above, or together with R 5 is a methylene chain of 3 to 5 carbon atoms such that a cycloalkyl of 4 to 6 carbon atoms inclusive is formed; R 5 is selected from the group consisting of hydrogen, straight-chain alkyl having from 1 to 3 carbon atoms or together with R 4 forms a cycloalkyl as defined above; and R 6 is hydrogen or straight-chain alkyl having from 1 to 3 carbon atoms are disclosed. PGE 1 ester analogues of the above formula, limited to the structures wherein two of R 2 , R 3 , R 4 and R 5 form a cycloalkyl, lower alkylated cycloalkyl, bicycloalkyl or bicycloalkenyl are also disclosed. n The prostaglandin analogues selectively produce bronchodilation and decrease gastric secretion in vivo. n Methods of preparing the analogues and starting materials required in the synthesis of the analogues are also disclosed.

    专利号:US-2014315720-A1
    优先权日:2012-10-24
    标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
    发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
    权利人:CELANESE ACETATE LLC
    摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Valic M, Pecotic R, Pavlinac Dodig I, Valic Z, Stipica I, Dogas Z. Intermittent hypercapnia-induced phrenic long-term depression is revealed after serotonin receptor blockade with methysergide in anaesthetized rats. Exp Physiol. 2016 Feb 1;101(2):319-31. doi: 10.1113/EP085161. Epub 2015 Dec 20. doi: 10.1016/j.physbeh.2015.07.014. Epub 2015 Jul 11. doi: 10.2515/therapie/2014030. Epub 2014 Jun 18. doi: 10.1016/j.expneurol.2013.05.006. Epub 2013 May 18.
    5: Hernekamp JF, Hu S, Schmidt K, Walther A, Lehnhardt M, Kremer T. Methysergide attenuates systemic burn edema in rats. Microvasc Res. 2013 Sep;89:115-21. doi: 10.1016/j.mvr.2013.03.002. Epub 2013 May 11. doi: 10.1111/j.1526-4610.2012.02124.x. Epub 2012 Mar 22. Review. doi: 10.1136/jnnp.2004.48363.ret2. doi: 10.1016/S0034-7094(10)70037-4. doi: 10.1007/s00221-010-2161-2. Epub 2010 Jan 20. doi: 10.1016/j.ejphar.2009.03.072. Epub 2009 Apr 6. Review.

    合成参考文献


    摘要:Psychotropic Drugs and Related Compounds, 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972, -(101), 1972
    参考文献:10.1007/bf01839187
    摘要:Kaya F, van Duin CTM, Veenendaal GH, van Miert ASJPAM. Food intake and rumen motility in dwarf goats. Effects of some serotonin receptor agonists and antagonists. Veterinary Research Communications. 1992 Sep;16(5):379–90. doi: 10.1007/bf01839187.
    参考文献:10.1007/bf01249082
    摘要:Rényi L, Archer T, Minor BG, Tandberg B, Fredriksson A, Ross SB. The inhibition of the cage-leaving response—A model for studies of the serotonergic neurotransmission in the rat. Journal of Neural Transmission. 1986 Sep;65(3-4):193–210. doi: 10.1007/bf01249082.
    参考文献:10.1007/bf00569660
    摘要:Illes P, von Falkenhausen S. Functional characterization of substance P receptors in the rabbit ear artery. Naunyn Schmiedebergs Arch Pharmacol. 1986 May;333(1):52–8. doi: 10.1007/bf00569660.
    参考文献:10.1007/bf00975049
    摘要:Ghosh(née Biswas) S, Poddar MK. Higher environmental temperature-induced increase in body temperature: Involvement of serotonin in GABA mediated interaction of opioidergic system. Neurochemical Research. 1993 Dec;18(12):1287–92. doi: 10.1007/bf00975049.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知